Onyx栓塞时代:脑动静脉畸形立体定向放射外科术前栓塞的系统综述与文献回顾
该系统综述通过PubMed检索纳入17项研究共1133例脑动静脉畸形患者,其中914例(80.7%)在立体定向放射外科前接受栓塞,Onyx用于340例(37.2%)。栓塞组平均闭塞率为46.9%,单纯放射外科组为46.5%;Onyx+放射外科组闭塞率为42.1%,非Onyx栓塞剂+放射外科组为50.0%。
要点
- 纳入17项研究共1133例患者,914例(80.7%)接受术前栓塞,Onyx用于340例(37.2%)。
- 栓塞组平均闭塞率46.9%,单纯放射外科组46.5%。
- Onyx+放射外科组闭塞率42.1%,非Onyx栓塞剂+放射外科组50.0%。
核心结论
- Onyx(乙烯-乙烯醇共聚物溶于二甲基亚砜并悬浮于微粉化钽粉中)越来越多地用于颅内动静脉畸形的栓塞,从技术角度其易用性提高,且表现与其他栓塞材料相似。
研究设计与样本
- 系统综述,通过PubMed检索纳入20例及以上动静脉畸形患者、报告栓塞材料及栓塞+立体定向放射外科(E+SRS)与单纯SRS组闭塞率的研究,最终纳入17篇文章共1133例符合条件患者。
主要发现
- 共914例(80.7%)患者在SRS前接受栓塞,E+SRS队列中340例(37.2%)使用Onyx作为栓塞剂。
- 栓塞组平均闭塞率为46.9%,单纯SRS组为46.5%。
- 按栓塞材料比较,Onyx+SRS组闭塞率为42.1%,非Onyx栓塞剂+SRS组为50.0%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The current treatment paradigm for intracranial arteriovenous malformations (AVMs) focuses on reducing the risk of intracranial hemorrhage using various therapeutic means including embolization, stereotactic radiosurgery (SRS), and microsurgical resection. To improve AVM obliteration rates with SRS, pre-radiosurgical embolization has been trialed in a number of studies to reduce the volume of the AVM nidus prior to radiosurgery. This study aimed to review the efficacy of pre-radiosurgical embolization in the pre-Onyx era compared to the current Onyx era. METHODS: A systematic review was performed using PubMed to identify studies with 20 or more AVM patients, embolization material, and obliteration rates for both embolization + stereotactic radiosurgery (E+SRS) and SRS-only groups. RESULTS: Seventeen articles consisting of 1133 eligible patients were included in this study. A total of 914 (80.7%) patients underwent embolization prior to SRS. Onyx was used as the embolysate in 340 (37.2%) patients in the E+SRS cohorts. Mean obliteration rate for the embolized cohort was 46.9% versus 46.5% in the SRS-only cohort. When comparing obliteration rates based on embolysate material, obliteration rate was 42.1% with Onyx+SRS and 50.0% in the non-Onyx embolysate + SRS cohort. CONCLUSIONS: Onyx (ethylene vinyl-alcohol copolymer dissolved in dimethyl sulfoxide and suspended in micronized tantalum powder) has been increasingly used for the embolization of intracranial AVMs with increased success regarding its ease of use from a technical standpoint and performs similarly to other embolysate materials.
引用
- Letchuman V, Mittal AM, Gupta HR, et al. The Era of Onyx Embolization: A Systematic and Literature Review of Preoperative Embolization Before Stereotactic Radiosurgery for the Management of Cerebral Arteriovenous Malformations. World Neurosurg. 2022. PMID: 36396047. doi:10.1016/j.wneu.2022.11.058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。